Selected research
Industry Research
Blood Proteomics Services Industry Research Report 2026
Market perspective
The global Blood Proteomics Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Blood Proteomics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Blood Proteomics Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Blood Proteomics Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Blood Proteomics Services include BostonGene, CellCarta, GENEWIZ (Azenta Life Sciences), CDI Labs, Biognosys, Discovery Life Sciences, Firalis Molecular Precision, Cell Signaling Technology (CST) and Sampled (Infinity Biologix), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Blood Proteomics Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Blood Proteomics Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Proteomics Services Market by Company
BostonGene
CellCarta
GENEWIZ (Azenta Life Sciences)
CDI Labs
Biognosys
Discovery Life Sciences
Firalis Molecular Precision
Cell Signaling Technology (CST)
Sampled (Infinity Biologix)
APTBIO
Sinotech Genomics
Biodesix
Panome Bio
Novogene
PTM BIO
BGI Genomics
Evotec
Metware Biotechnology
MRM Proteomics
Lc-Bio Technologies
Eurofins Scientific
MtoZ-Biolabs
Creative Proteomics
Macrogen
TATAA Biocenter
OmicScouts (Momentum Biotechnologies)
Precision Biomarker Laboratories (PBL)
Shanghai OE Biotech
RxCelerate
Proteomics International
Proteome Sciences
Westlake Omics
Crown Bioscience
VProteomics
Shanghai Majorbio Bio-Pharm
Applied Biomics
Sapient Bioanalytics
Allumiqs
MS Bioworks
Shanghai Bioprofile
Cosmos Wisdom
Olink (Thermo Fisher Scientific)
SomaLogic (Illumina)
Labcorp
Blood Proteomics Services Segment by Type
Blood Proteomics
Blood Modification Proteomics
Olink (Targeted) Proteomics
Blood Proteomics Services Segment by Application
Disease Biomarker Research
Drug Development
Clinical Research
Others
Blood Proteomics Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Proteomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Proteomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Proteomics Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blood Proteomics Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Blood Proteomics Services Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Blood Proteomics Services Revenue Market Share by Type (2021-2026)
Table 7. Global Blood Proteomics Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Blood Proteomics Services Revenue Market Share by Type (2027-2032)
Table 9. Global Blood Proteomics Services Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Blood Proteomics Services Revenue Market Share by Application (2021-2026)
Table 11. Global Blood Proteomics Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Blood Proteomics Services Revenue Market Share by Application (2027-2032)
Table 13. Global Blood Proteomics Services Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Blood Proteomics Services Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Blood Proteomics Services Market Share by Region (2021-2026)
Table 16. Global Blood Proteomics Services Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Blood Proteomics Services Market Share by Region (2027-2032)
Table 18. Blood Proteomics Services Industry Trends
Table 19. Blood Proteomics Services Industry Drivers
Table 20. Blood Proteomics Services Industry Opportunities and Challenges
Table 21. Blood Proteomics Services Market Restraints
Table 22. Global Top Blood Proteomics Services Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Blood Proteomics Services Revenue Market Share by Players (2021-2026)
Table 24. Global Blood Proteomics Services Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Blood Proteomics Services, Headquarters and Area Served
Table 26. Global Blood Proteomics Services Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Blood Proteomics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Blood Proteomics Services Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Blood Proteomics Services Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Blood Proteomics Services Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Blood Proteomics Services Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Blood Proteomics Services Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Blood Proteomics Services Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Blood Proteomics Services Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Blood Proteomics Services Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Blood Proteomics Services Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Blood Proteomics Services Market Size by Country (2027-2032) & (US$ Million)
Table 45. BostonGene Company Information
Table 46. BostonGene Business Overview
Table 47. BostonGene Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 48. BostonGene Blood Proteomics Services Product Portfolio
Table 49. BostonGene Recent Developments
Table 50. CellCarta Company Information
Table 51. CellCarta Business Overview
Table 52. CellCarta Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 53. CellCarta Blood Proteomics Services Product Portfolio
Table 54. CellCarta Recent Developments
Table 55. GENEWIZ (Azenta Life Sciences) Company Information
Table 56. GENEWIZ (Azenta Life Sciences) Business Overview
Table 57. GENEWIZ (Azenta Life Sciences) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 58. GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio
Table 59. GENEWIZ (Azenta Life Sciences) Recent Developments
Table 60. CDI Labs Company Information
Table 61. CDI Labs Business Overview
Table 62. CDI Labs Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 63. CDI Labs Blood Proteomics Services Product Portfolio
Table 64. CDI Labs Recent Developments
Table 65. Biognosys Company Information
Table 66. Biognosys Business Overview
Table 67. Biognosys Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 68. Biognosys Blood Proteomics Services Product Portfolio
Table 69. Biognosys Recent Developments
Table 70. Discovery Life Sciences Company Information
Table 71. Discovery Life Sciences Business Overview
Table 72. Discovery Life Sciences Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 73. Discovery Life Sciences Blood Proteomics Services Product Portfolio
Table 74. Discovery Life Sciences Recent Developments
Table 75. Firalis Molecular Precision Company Information
Table 76. Firalis Molecular Precision Business Overview
Table 77. Firalis Molecular Precision Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 78. Firalis Molecular Precision Blood Proteomics Services Product Portfolio
Table 79. Firalis Molecular Precision Recent Developments
Table 80. Cell Signaling Technology (CST) Company Information
Table 81. Cell Signaling Technology (CST) Business Overview
Table 82. Cell Signaling Technology (CST) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 83. Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio
Table 84. Cell Signaling Technology (CST) Recent Developments
Table 85. Sampled (Infinity Biologix) Company Information
Table 86. Sampled (Infinity Biologix) Business Overview
Table 87. Sampled (Infinity Biologix) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 88. Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio
Table 89. Sampled (Infinity Biologix) Recent Developments
Table 90. APTBIO Company Information
Table 91. APTBIO Business Overview
Table 92. APTBIO Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 93. APTBIO Blood Proteomics Services Product Portfolio
Table 94. APTBIO Recent Developments
Table 95. Sinotech Genomics Company Information
Table 96. Sinotech Genomics Business Overview
Table 97. Sinotech Genomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 98. Sinotech Genomics Blood Proteomics Services Product Portfolio
Table 99. Sinotech Genomics Recent Developments
Table 100. Biodesix Company Information
Table 101. Biodesix Business Overview
Table 102. Biodesix Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 103. Biodesix Blood Proteomics Services Product Portfolio
Table 104. Biodesix Recent Developments
Table 105. Panome Bio Company Information
Table 106. Panome Bio Business Overview
Table 107. Panome Bio Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 108. Panome Bio Blood Proteomics Services Product Portfolio
Table 109. Panome Bio Recent Developments
Table 110. Novogene Company Information
Table 111. Novogene Business Overview
Table 112. Novogene Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 113. Novogene Blood Proteomics Services Product Portfolio
Table 114. Novogene Recent Developments
Table 115. PTM BIO Company Information
Table 116. PTM BIO Business Overview
Table 117. PTM BIO Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 118. PTM BIO Blood Proteomics Services Product Portfolio
Table 119. PTM BIO Recent Developments
Table 120. BGI Genomics Company Information
Table 121. BGI Genomics Business Overview
Table 122. BGI Genomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 123. BGI Genomics Blood Proteomics Services Product Portfolio
Table 124. BGI Genomics Recent Developments
Table 125. Evotec Company Information
Table 126. Evotec Business Overview
Table 127. Evotec Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 128. Evotec Blood Proteomics Services Product Portfolio
Table 129. Evotec Recent Developments
Table 130. Metware Biotechnology Company Information
Table 131. Metware Biotechnology Business Overview
Table 132. Metware Biotechnology Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 133. Metware Biotechnology Blood Proteomics Services Product Portfolio
Table 134. Metware Biotechnology Recent Developments
Table 135. MRM Proteomics Company Information
Table 136. MRM Proteomics Business Overview
Table 137. MRM Proteomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 138. MRM Proteomics Blood Proteomics Services Product Portfolio
Table 139. MRM Proteomics Recent Developments
Table 140. Lc-Bio Technologies Company Information
Table 141. Lc-Bio Technologies Business Overview
Table 142. Lc-Bio Technologies Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 143. Lc-Bio Technologies Blood Proteomics Services Product Portfolio
Table 144. Lc-Bio Technologies Recent Developments
Table 145. Eurofins Scientific Company Information
Table 146. Eurofins Scientific Business Overview
Table 147. Eurofins Scientific Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 148. Eurofins Scientific Blood Proteomics Services Product Portfolio
Table 149. Eurofins Scientific Recent Developments
Table 150. MtoZ-Biolabs Company Information
Table 151. MtoZ-Biolabs Business Overview
Table 152. MtoZ-Biolabs Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 153. MtoZ-Biolabs Blood Proteomics Services Product Portfolio
Table 154. MtoZ-Biolabs Recent Developments
Table 155. Creative Proteomics Company Information
Table 156. Creative Proteomics Business Overview
Table 157. Creative Proteomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 158. Creative Proteomics Blood Proteomics Services Product Portfolio
Table 159. Creative Proteomics Recent Developments
Table 160. Macrogen Company Information
Table 161. Macrogen Business Overview
Table 162. Macrogen Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 163. Macrogen Blood Proteomics Services Product Portfolio
Table 164. Macrogen Recent Developments
Table 165. TATAA Biocenter Company Information
Table 166. TATAA Biocenter Business Overview
Table 167. TATAA Biocenter Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 168. TATAA Biocenter Blood Proteomics Services Product Portfolio
Table 169. TATAA Biocenter Recent Developments
Table 170. OmicScouts (Momentum Biotechnologies) Company Information
Table 171. OmicScouts (Momentum Biotechnologies) Business Overview
Table 172. OmicScouts (Momentum Biotechnologies) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 173. OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio
Table 174. OmicScouts (Momentum Biotechnologies) Recent Developments
Table 175. Precision Biomarker Laboratories (PBL) Company Information
Table 176. Precision Biomarker Laboratories (PBL) Business Overview
Table 177. Precision Biomarker Laboratories (PBL) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 178. Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio
Table 179. Precision Biomarker Laboratories (PBL) Recent Developments
Table 180. Shanghai OE Biotech Company Information
Table 181. Shanghai OE Biotech Business Overview
Table 182. Shanghai OE Biotech Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 183. Shanghai OE Biotech Blood Proteomics Services Product Portfolio
Table 184. Shanghai OE Biotech Recent Developments
Table 185. RxCelerate Company Information
Table 186. RxCelerate Business Overview
Table 187. RxCelerate Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 188. RxCelerate Blood Proteomics Services Product Portfolio
Table 189. RxCelerate Recent Developments
Table 190. Proteomics International Company Information
Table 191. Proteomics International Business Overview
Table 192. Proteomics International Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 193. Proteomics International Blood Proteomics Services Product Portfolio
Table 194. Proteomics International Recent Developments
Table 195. Proteome Sciences Company Information
Table 196. Proteome Sciences Business Overview
Table 197. Proteome Sciences Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 198. Proteome Sciences Blood Proteomics Services Product Portfolio
Table 199. Proteome Sciences Recent Developments
Table 200. Westlake Omics Company Information
Table 201. Westlake Omics Business Overview
Table 202. Westlake Omics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 203. Westlake Omics Blood Proteomics Services Product Portfolio
Table 204. Westlake Omics Recent Developments
Table 205. Crown Bioscience Company Information
Table 206. Crown Bioscience Business Overview
Table 207. Crown Bioscience Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 208. Crown Bioscience Blood Proteomics Services Product Portfolio
Table 209. Crown Bioscience Recent Developments
Table 210. VProteomics Company Information
Table 211. VProteomics Business Overview
Table 212. VProteomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 213. VProteomics Blood Proteomics Services Product Portfolio
Table 214. VProteomics Recent Developments
Table 215. Shanghai Majorbio Bio-Pharm Company Information
Table 216. Shanghai Majorbio Bio-Pharm Business Overview
Table 217. Shanghai Majorbio Bio-Pharm Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 218. Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio
Table 219. Shanghai Majorbio Bio-Pharm Recent Developments
Table 220. Applied Biomics Company Information
Table 221. Applied Biomics Business Overview
Table 222. Applied Biomics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 223. Applied Biomics Blood Proteomics Services Product Portfolio
Table 224. Applied Biomics Recent Developments
Table 225. Sapient Bioanalytics Company Information
Table 226. Sapient Bioanalytics Business Overview
Table 227. Sapient Bioanalytics Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 228. Sapient Bioanalytics Blood Proteomics Services Product Portfolio
Table 229. Sapient Bioanalytics Recent Developments
Table 230. Allumiqs Company Information
Table 231. Allumiqs Business Overview
Table 232. Allumiqs Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 233. Allumiqs Blood Proteomics Services Product Portfolio
Table 234. Allumiqs Recent Developments
Table 235. MS Bioworks Company Information
Table 236. MS Bioworks Business Overview
Table 237. MS Bioworks Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 238. MS Bioworks Blood Proteomics Services Product Portfolio
Table 239. MS Bioworks Recent Developments
Table 240. Shanghai Bioprofile Company Information
Table 241. Shanghai Bioprofile Business Overview
Table 242. Shanghai Bioprofile Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 243. Shanghai Bioprofile Blood Proteomics Services Product Portfolio
Table 244. Shanghai Bioprofile Recent Developments
Table 245. Cosmos Wisdom Company Information
Table 246. Cosmos Wisdom Business Overview
Table 247. Cosmos Wisdom Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 248. Cosmos Wisdom Blood Proteomics Services Product Portfolio
Table 249. Cosmos Wisdom Recent Developments
Table 250. Olink (Thermo Fisher Scientific) Company Information
Table 251. Olink (Thermo Fisher Scientific) Business Overview
Table 252. Olink (Thermo Fisher Scientific) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 253. Olink (Thermo Fisher Scientific) Blood Proteomics Services Product Portfolio
Table 254. Olink (Thermo Fisher Scientific) Recent Developments
Table 255. SomaLogic (Illumina) Company Information
Table 256. SomaLogic (Illumina) Business Overview
Table 257. SomaLogic (Illumina) Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 258. SomaLogic (Illumina) Blood Proteomics Services Product Portfolio
Table 259. SomaLogic (Illumina) Recent Developments
Table 260. Labcorp Company Information
Table 261. Labcorp Business Overview
Table 262. Labcorp Revenue in Blood Proteomics Services Business (2021-2026) & (US$ Million)
Table 263. Labcorp Blood Proteomics Services Product Portfolio
Table 264. Labcorp Recent Developments
Table 265. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Blood Proteomics Services Product Image
Figure 5. Global Blood Proteomics Services Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Blood Proteomics Services Market Share by Type: 2025 VS 2032
Figure 7. Blood Proteomics Product
Figure 8. Blood Modification Proteomics Product
Figure 9. Olink (Targeted) Proteomics Product
Figure 10. Global Blood Proteomics Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Blood Proteomics Services Market Share by Application: 2025 VS 2032
Figure 12. Disease Biomarker Research Product
Figure 13. Drug Development Product
Figure 14. Clinical Research Product
Figure 15. Others Product
Figure 16. Global Blood Proteomics Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Blood Proteomics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Blood Proteomics Services Market Share by Region: 2025 VS 2032
Figure 19. Global Blood Proteomics Services Market Share by Players in 2025
Figure 20. Global Blood Proteomics Services Manufacturers Established Date
Figure 21. Global Top 5 and 10 Blood Proteomics Services Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Blood Proteomics Services Market Share by Country (2021-2032)
Figure 25. United States Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Blood Proteomics Services Market Share by Country (2021-2032)
Figure 28. Europe Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Blood Proteomics Services Market Share by Country (2021-2032)
Figure 30. Germany Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Blood Proteomics Services Market Share by Country (2021-2032)
Figure 40. China Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Blood Proteomics Services Market Share by Country (2021-2032)
Figure 45. Australia Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Blood Proteomics Services Market Share by Country (2021-2032)
Figure 50. Brazil Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Blood Proteomics Services Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. BostonGene Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 56. CellCarta Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 57. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 58. CDI Labs Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 59. Biognosys Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 60. Discovery Life Sciences Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 61. Firalis Molecular Precision Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 62. Cell Signaling Technology (CST) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 63. Sampled (Infinity Biologix) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 64. APTBIO Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 65. Sinotech Genomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 66. Biodesix Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 67. Panome Bio Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 68. Novogene Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 69. PTM BIO Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 70. BGI Genomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 71. Evotec Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 72. Metware Biotechnology Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 73. MRM Proteomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 74. Lc-Bio Technologies Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 75. Eurofins Scientific Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 76. MtoZ-Biolabs Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 77. Creative Proteomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 78. Macrogen Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 79. TATAA Biocenter Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 80. OmicScouts (Momentum Biotechnologies) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 81. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 82. Shanghai OE Biotech Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 83. RxCelerate Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 84. Proteomics International Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 85. Proteome Sciences Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 86. Westlake Omics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 87. Crown Bioscience Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 88. VProteomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 89. Shanghai Majorbio Bio-Pharm Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 90. Applied Biomics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 91. Sapient Bioanalytics Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 92. Allumiqs Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 93. MS Bioworks Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 94. Shanghai Bioprofile Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 95. Cosmos Wisdom Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 96. Olink (Thermo Fisher Scientific) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 97. SomaLogic (Illumina) Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Figure 98. Labcorp Revenue Growth Rate in Blood Proteomics Services Business (2021-2026)
Scope & coverage.
Types
- Blood Proteomics
- Blood Modification Proteomics
- Olink (Targeted) Proteomics
Applications
- Disease Biomarker Research
- Drug Development
- Clinical Research
- Others
Companies covered
- BostonGene
- CellCarta
- GENEWIZ (Azenta Life Sciences)
- CDI Labs
- Biognosys
- Discovery Life Sciences
- Firalis Molecular Precision
- Cell Signaling Technology (CST)
- Sampled (Infinity Biologix)
- APTBIO
- Sinotech Genomics
- Biodesix
- Panome Bio
- Novogene
- PTM BIO
- BGI Genomics
- Evotec
- Metware Biotechnology
- MRM Proteomics
- Lc-Bio Technologies
- Eurofins Scientific
- MtoZ-Biolabs
- Creative Proteomics
- Macrogen
- TATAA Biocenter
- OmicScouts (Momentum Biotechnologies)
- Precision Biomarker Laboratories (PBL)
- Shanghai OE Biotech
- RxCelerate
- Proteomics International
- Proteome Sciences
- Westlake Omics
- Crown Bioscience
- VProteomics
- Shanghai Majorbio Bio-Pharm
- Applied Biomics
- Sapient Bioanalytics
- Allumiqs
- MS Bioworks
- Shanghai Bioprofile
- Cosmos Wisdom
- Olink (Thermo Fisher Scientific)
- SomaLogic (Illumina)
- Labcorp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Blood Proteomics Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Proteomics
- 2.2.3 Blood Modification Proteomics
- 2.2.4 Olink (Targeted) Proteomics
- 2.3 Blood Proteomics Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Disease Biomarker Research
- 2.3.3 Drug Development
- 2.3.4 Clinical Research
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Blood Proteomics Services Breakdown Data by Type
- 3.1 Global Blood Proteomics Services Historic Market Size by Type (2021-2026)
- 3.2 Global Blood Proteomics Services Forecasted Market Size by Type (2027-2032)
4 Blood Proteomics Services Breakdown Data by Application
- 4.1 Global Blood Proteomics Services Historic Market Size by Application (2021-2026)
- 4.2 Global Blood Proteomics Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Blood Proteomics Services Market Perspective (2021-2032)
- 5.2 Global Blood Proteomics Services Growth Trends by Region
- 5.2.1 Global Blood Proteomics Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Blood Proteomics Services Historic Market Size by Region (2021-2026)
- 5.2.3 Blood Proteomics Services Forecasted Market Size by Region (2027-2032)
- 5.3 Blood Proteomics Services Market Dynamics
- 5.3.1 Blood Proteomics Services Industry Trends
- 5.3.2 Blood Proteomics Services Market Drivers
- 5.3.3 Blood Proteomics Services Market Challenges
- 5.3.4 Blood Proteomics Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Blood Proteomics Services Players by Revenue
- 6.1.1 Global Top Blood Proteomics Services Players by Revenue (2021-2026)
- 6.1.2 Global Blood Proteomics Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Blood Proteomics Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blood Proteomics Services Head Office and Area Served
- 6.4 Global Blood Proteomics Services Players, Product Type & Application
- 6.5 Global Blood Proteomics Services Manufacturers Established Date
- 6.6 Global Blood Proteomics Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Blood Proteomics Services Market Size (2021-2032)
- 7.2 North America Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Blood Proteomics Services Market Size by Country (2021-2026)
- 7.4 North America Blood Proteomics Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Blood Proteomics Services Market Size (2021-2032)
- 8.2 Europe Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Blood Proteomics Services Market Size by Country (2021-2026)
- 8.4 Europe Blood Proteomics Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Blood Proteomics Services Market Size (2021-2032)
- 9.2 Asia-Pacific Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Blood Proteomics Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Blood Proteomics Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Blood Proteomics Services Market Size (2021-2032)
- 10.2 South America Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Blood Proteomics Services Market Size by Country (2021-2026)
- 10.4 South America Blood Proteomics Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Blood Proteomics Services Market Size (2021-2032)
- 11.2 Middle East & Africa Blood Proteomics Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Blood Proteomics Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Blood Proteomics Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BostonGene
- 12.1.1 BostonGene Company Information
- 12.1.2 BostonGene Business Overview
- 12.1.3 BostonGene Revenue in Blood Proteomics Services Business (2021-2026)
- 12.1.4 BostonGene Blood Proteomics Services Product Portfolio
- 12.1.5 BostonGene Recent Developments
- 12.2 CellCarta
- 12.2.1 CellCarta Company Information
- 12.2.2 CellCarta Business Overview
- 12.2.3 CellCarta Revenue in Blood Proteomics Services Business (2021-2026)
- 12.2.4 CellCarta Blood Proteomics Services Product Portfolio
- 12.2.5 CellCarta Recent Developments
- 12.3 GENEWIZ (Azenta Life Sciences)
- 12.3.1 GENEWIZ (Azenta Life Sciences) Company Information
- 12.3.2 GENEWIZ (Azenta Life Sciences) Business Overview
- 12.3.3 GENEWIZ (Azenta Life Sciences) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.3.4 GENEWIZ (Azenta Life Sciences) Blood Proteomics Services Product Portfolio
- 12.3.5 GENEWIZ (Azenta Life Sciences) Recent Developments
- 12.4 CDI Labs
- 12.4.1 CDI Labs Company Information
- 12.4.2 CDI Labs Business Overview
- 12.4.3 CDI Labs Revenue in Blood Proteomics Services Business (2021-2026)
- 12.4.4 CDI Labs Blood Proteomics Services Product Portfolio
- 12.4.5 CDI Labs Recent Developments
- 12.5 Biognosys
- 12.5.1 Biognosys Company Information
- 12.5.2 Biognosys Business Overview
- 12.5.3 Biognosys Revenue in Blood Proteomics Services Business (2021-2026)
- 12.5.4 Biognosys Blood Proteomics Services Product Portfolio
- 12.5.5 Biognosys Recent Developments
- 12.6 Discovery Life Sciences
- 12.6.1 Discovery Life Sciences Company Information
- 12.6.2 Discovery Life Sciences Business Overview
- 12.6.3 Discovery Life Sciences Revenue in Blood Proteomics Services Business (2021-2026)
- 12.6.4 Discovery Life Sciences Blood Proteomics Services Product Portfolio
- 12.6.5 Discovery Life Sciences Recent Developments
- 12.7 Firalis Molecular Precision
- 12.7.1 Firalis Molecular Precision Company Information
- 12.7.2 Firalis Molecular Precision Business Overview
- 12.7.3 Firalis Molecular Precision Revenue in Blood Proteomics Services Business (2021-2026)
- 12.7.4 Firalis Molecular Precision Blood Proteomics Services Product Portfolio
- 12.7.5 Firalis Molecular Precision Recent Developments
- 12.8 Cell Signaling Technology (CST)
- 12.8.1 Cell Signaling Technology (CST) Company Information
- 12.8.2 Cell Signaling Technology (CST) Business Overview
- 12.8.3 Cell Signaling Technology (CST) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.8.4 Cell Signaling Technology (CST) Blood Proteomics Services Product Portfolio
- 12.8.5 Cell Signaling Technology (CST) Recent Developments
- 12.9 Sampled (Infinity Biologix)
- 12.9.1 Sampled (Infinity Biologix) Company Information
- 12.9.2 Sampled (Infinity Biologix) Business Overview
- 12.9.3 Sampled (Infinity Biologix) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.9.4 Sampled (Infinity Biologix) Blood Proteomics Services Product Portfolio
- 12.9.5 Sampled (Infinity Biologix) Recent Developments
- 12.10 APTBIO
- 12.10.1 APTBIO Company Information
- 12.10.2 APTBIO Business Overview
- 12.10.3 APTBIO Revenue in Blood Proteomics Services Business (2021-2026)
- 12.10.4 APTBIO Blood Proteomics Services Product Portfolio
- 12.10.5 APTBIO Recent Developments
- 12.11 Sinotech Genomics
- 12.11.1 Sinotech Genomics Company Information
- 12.11.2 Sinotech Genomics Business Overview
- 12.11.3 Sinotech Genomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.11.4 Sinotech Genomics Blood Proteomics Services Product Portfolio
- 12.11.5 Sinotech Genomics Recent Developments
- 12.12 Biodesix
- 12.12.1 Biodesix Company Information
- 12.12.2 Biodesix Business Overview
- 12.12.3 Biodesix Revenue in Blood Proteomics Services Business (2021-2026)
- 12.12.4 Biodesix Blood Proteomics Services Product Portfolio
- 12.12.5 Biodesix Recent Developments
- 12.13 Panome Bio
- 12.13.1 Panome Bio Company Information
- 12.13.2 Panome Bio Business Overview
- 12.13.3 Panome Bio Revenue in Blood Proteomics Services Business (2021-2026)
- 12.13.4 Panome Bio Blood Proteomics Services Product Portfolio
- 12.13.5 Panome Bio Recent Developments
- 12.14 Novogene
- 12.14.1 Novogene Company Information
- 12.14.2 Novogene Business Overview
- 12.14.3 Novogene Revenue in Blood Proteomics Services Business (2021-2026)
- 12.14.4 Novogene Blood Proteomics Services Product Portfolio
- 12.14.5 Novogene Recent Developments
- 12.15 PTM BIO
- 12.15.1 PTM BIO Company Information
- 12.15.2 PTM BIO Business Overview
- 12.15.3 PTM BIO Revenue in Blood Proteomics Services Business (2021-2026)
- 12.15.4 PTM BIO Blood Proteomics Services Product Portfolio
- 12.15.5 PTM BIO Recent Developments
- 12.16 BGI Genomics
- 12.16.1 BGI Genomics Company Information
- 12.16.2 BGI Genomics Business Overview
- 12.16.3 BGI Genomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.16.4 BGI Genomics Blood Proteomics Services Product Portfolio
- 12.16.5 BGI Genomics Recent Developments
- 12.17 Evotec
- 12.17.1 Evotec Company Information
- 12.17.2 Evotec Business Overview
- 12.17.3 Evotec Revenue in Blood Proteomics Services Business (2021-2026)
- 12.17.4 Evotec Blood Proteomics Services Product Portfolio
- 12.17.5 Evotec Recent Developments
- 12.18 Metware Biotechnology
- 12.18.1 Metware Biotechnology Company Information
- 12.18.2 Metware Biotechnology Business Overview
- 12.18.3 Metware Biotechnology Revenue in Blood Proteomics Services Business (2021-2026)
- 12.18.4 Metware Biotechnology Blood Proteomics Services Product Portfolio
- 12.18.5 Metware Biotechnology Recent Developments
- 12.19 MRM Proteomics
- 12.19.1 MRM Proteomics Company Information
- 12.19.2 MRM Proteomics Business Overview
- 12.19.3 MRM Proteomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.19.4 MRM Proteomics Blood Proteomics Services Product Portfolio
- 12.19.5 MRM Proteomics Recent Developments
- 12.20 Lc-Bio Technologies
- 12.20.1 Lc-Bio Technologies Company Information
- 12.20.2 Lc-Bio Technologies Business Overview
- 12.20.3 Lc-Bio Technologies Revenue in Blood Proteomics Services Business (2021-2026)
- 12.20.4 Lc-Bio Technologies Blood Proteomics Services Product Portfolio
- 12.20.5 Lc-Bio Technologies Recent Developments
- 12.21 Eurofins Scientific
- 12.21.1 Eurofins Scientific Company Information
- 12.21.2 Eurofins Scientific Business Overview
- 12.21.3 Eurofins Scientific Revenue in Blood Proteomics Services Business (2021-2026)
- 12.21.4 Eurofins Scientific Blood Proteomics Services Product Portfolio
- 12.21.5 Eurofins Scientific Recent Developments
- 12.22 MtoZ-Biolabs
- 12.22.1 MtoZ-Biolabs Company Information
- 12.22.2 MtoZ-Biolabs Business Overview
- 12.22.3 MtoZ-Biolabs Revenue in Blood Proteomics Services Business (2021-2026)
- 12.22.4 MtoZ-Biolabs Blood Proteomics Services Product Portfolio
- 12.22.5 MtoZ-Biolabs Recent Developments
- 12.23 Creative Proteomics
- 12.23.1 Creative Proteomics Company Information
- 12.23.2 Creative Proteomics Business Overview
- 12.23.3 Creative Proteomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.23.4 Creative Proteomics Blood Proteomics Services Product Portfolio
- 12.23.5 Creative Proteomics Recent Developments
- 12.24 Macrogen
- 12.24.1 Macrogen Company Information
- 12.24.2 Macrogen Business Overview
- 12.24.3 Macrogen Revenue in Blood Proteomics Services Business (2021-2026)
- 12.24.4 Macrogen Blood Proteomics Services Product Portfolio
- 12.24.5 Macrogen Recent Developments
- 12.25 TATAA Biocenter
- 12.25.1 TATAA Biocenter Company Information
- 12.25.2 TATAA Biocenter Business Overview
- 12.25.3 TATAA Biocenter Revenue in Blood Proteomics Services Business (2021-2026)
- 12.25.4 TATAA Biocenter Blood Proteomics Services Product Portfolio
- 12.25.5 TATAA Biocenter Recent Developments
- 12.26 OmicScouts (Momentum Biotechnologies)
- 12.26.1 OmicScouts (Momentum Biotechnologies) Company Information
- 12.26.2 OmicScouts (Momentum Biotechnologies) Business Overview
- 12.26.3 OmicScouts (Momentum Biotechnologies) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.26.4 OmicScouts (Momentum Biotechnologies) Blood Proteomics Services Product Portfolio
- 12.26.5 OmicScouts (Momentum Biotechnologies) Recent Developments
- 12.27 Precision Biomarker Laboratories (PBL)
- 12.27.1 Precision Biomarker Laboratories (PBL) Company Information
- 12.27.2 Precision Biomarker Laboratories (PBL) Business Overview
- 12.27.3 Precision Biomarker Laboratories (PBL) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.27.4 Precision Biomarker Laboratories (PBL) Blood Proteomics Services Product Portfolio
- 12.27.5 Precision Biomarker Laboratories (PBL) Recent Developments
- 12.28 Shanghai OE Biotech
- 12.28.1 Shanghai OE Biotech Company Information
- 12.28.2 Shanghai OE Biotech Business Overview
- 12.28.3 Shanghai OE Biotech Revenue in Blood Proteomics Services Business (2021-2026)
- 12.28.4 Shanghai OE Biotech Blood Proteomics Services Product Portfolio
- 12.28.5 Shanghai OE Biotech Recent Developments
- 12.29 RxCelerate
- 12.29.1 RxCelerate Company Information
- 12.29.2 RxCelerate Business Overview
- 12.29.3 RxCelerate Revenue in Blood Proteomics Services Business (2021-2026)
- 12.29.4 RxCelerate Blood Proteomics Services Product Portfolio
- 12.29.5 RxCelerate Recent Developments
- 12.30 Proteomics International
- 12.30.1 Proteomics International Company Information
- 12.30.2 Proteomics International Business Overview
- 12.30.3 Proteomics International Revenue in Blood Proteomics Services Business (2021-2026)
- 12.30.4 Proteomics International Blood Proteomics Services Product Portfolio
- 12.30.5 Proteomics International Recent Developments
- 12.31 Proteome Sciences
- 12.31.1 Proteome Sciences Company Information
- 12.31.2 Proteome Sciences Business Overview
- 12.31.3 Proteome Sciences Revenue in Blood Proteomics Services Business (2021-2026)
- 12.31.4 Proteome Sciences Blood Proteomics Services Product Portfolio
- 12.31.5 Proteome Sciences Recent Developments
- 12.32 Westlake Omics
- 12.32.1 Westlake Omics Company Information
- 12.32.2 Westlake Omics Business Overview
- 12.32.3 Westlake Omics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.32.4 Westlake Omics Blood Proteomics Services Product Portfolio
- 12.32.5 Westlake Omics Recent Developments
- 12.33 Crown Bioscience
- 12.33.1 Crown Bioscience Company Information
- 12.33.2 Crown Bioscience Business Overview
- 12.33.3 Crown Bioscience Revenue in Blood Proteomics Services Business (2021-2026)
- 12.33.4 Crown Bioscience Blood Proteomics Services Product Portfolio
- 12.33.5 Crown Bioscience Recent Developments
- 12.34 VProteomics
- 12.34.1 VProteomics Company Information
- 12.34.2 VProteomics Business Overview
- 12.34.3 VProteomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.34.4 VProteomics Blood Proteomics Services Product Portfolio
- 12.34.5 VProteomics Recent Developments
- 12.35 Shanghai Majorbio Bio-Pharm
- 12.35.1 Shanghai Majorbio Bio-Pharm Company Information
- 12.35.2 Shanghai Majorbio Bio-Pharm Business Overview
- 12.35.3 Shanghai Majorbio Bio-Pharm Revenue in Blood Proteomics Services Business (2021-2026)
- 12.35.4 Shanghai Majorbio Bio-Pharm Blood Proteomics Services Product Portfolio
- 12.35.5 Shanghai Majorbio Bio-Pharm Recent Developments
- 12.36 Applied Biomics
- 12.36.1 Applied Biomics Company Information
- 12.36.2 Applied Biomics Business Overview
- 12.36.3 Applied Biomics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.36.4 Applied Biomics Blood Proteomics Services Product Portfolio
- 12.36.5 Applied Biomics Recent Developments
- 12.37 Sapient Bioanalytics
- 12.37.1 Sapient Bioanalytics Company Information
- 12.37.2 Sapient Bioanalytics Business Overview
- 12.37.3 Sapient Bioanalytics Revenue in Blood Proteomics Services Business (2021-2026)
- 12.37.4 Sapient Bioanalytics Blood Proteomics Services Product Portfolio
- 12.37.5 Sapient Bioanalytics Recent Developments
- 12.38 Allumiqs
- 12.38.1 Allumiqs Company Information
- 12.38.2 Allumiqs Business Overview
- 12.38.3 Allumiqs Revenue in Blood Proteomics Services Business (2021-2026)
- 12.38.4 Allumiqs Blood Proteomics Services Product Portfolio
- 12.38.5 Allumiqs Recent Developments
- 12.39 MS Bioworks
- 12.39.1 MS Bioworks Company Information
- 12.39.2 MS Bioworks Business Overview
- 12.39.3 MS Bioworks Revenue in Blood Proteomics Services Business (2021-2026)
- 12.39.4 MS Bioworks Blood Proteomics Services Product Portfolio
- 12.39.5 MS Bioworks Recent Developments
- 12.40 Shanghai Bioprofile
- 12.40.1 Shanghai Bioprofile Company Information
- 12.40.2 Shanghai Bioprofile Business Overview
- 12.40.3 Shanghai Bioprofile Revenue in Blood Proteomics Services Business (2021-2026)
- 12.40.4 Shanghai Bioprofile Blood Proteomics Services Product Portfolio
- 12.40.5 Shanghai Bioprofile Recent Developments
- 12.41 Cosmos Wisdom
- 12.41.1 Cosmos Wisdom Company Information
- 12.41.2 Cosmos Wisdom Business Overview
- 12.41.3 Cosmos Wisdom Revenue in Blood Proteomics Services Business (2021-2026)
- 12.41.4 Cosmos Wisdom Blood Proteomics Services Product Portfolio
- 12.41.5 Cosmos Wisdom Recent Developments
- 12.42 Olink (Thermo Fisher Scientific)
- 12.42.1 Olink (Thermo Fisher Scientific) Company Information
- 12.42.2 Olink (Thermo Fisher Scientific) Business Overview
- 12.42.3 Olink (Thermo Fisher Scientific) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.42.4 Olink (Thermo Fisher Scientific) Blood Proteomics Services Product Portfolio
- 12.42.5 Olink (Thermo Fisher Scientific) Recent Developments
- 12.43 SomaLogic (Illumina)
- 12.43.1 SomaLogic (Illumina) Company Information
- 12.43.2 SomaLogic (Illumina) Business Overview
- 12.43.3 SomaLogic (Illumina) Revenue in Blood Proteomics Services Business (2021-2026)
- 12.43.4 SomaLogic (Illumina) Blood Proteomics Services Product Portfolio
- 12.43.5 SomaLogic (Illumina) Recent Developments
- 12.44 Labcorp
- 12.44.1 Labcorp Company Information
- 12.44.2 Labcorp Business Overview
- 12.44.3 Labcorp Revenue in Blood Proteomics Services Business (2021-2026)
- 12.44.4 Labcorp Blood Proteomics Services Product Portfolio
- 12.44.5 Labcorp Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst